University of Colorado Cancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining failure of retinoic acid trials against breast cancer and offers a possible strategy for their ...
(University of Colorado Anschutz Medical Campus) 'What has been missing in clinical trials may just be the timing of the treatments,' says first author Lynsey Fettig.
Researchers analyzed data confirming the improved outcomes in both short- and long-term survival in patients that underwent neoadjuvant chemotherapy prior to surgery for triple-negative breast cancer. The study included 213 patientsShow More Summary
(University of Pennsylvania School of Medicine) Women undergoing daily radiation therapy for breast cancer are commonly told they should not use antiperspirant for fear that it could cause greater radiation damage to the skin, but aShow More Summary
Women undergoing daily radiation therapy for breast cancer are commonly told they should not use antiperspirant for fear that it could cause greater radiation damage to the skin, but a new study from the Perelman School of Medicine at...Show More Summary
Earlier this month, cancer quacks everywhere were touting a study that suggests that chemotherapy administered before breast cancer treatment can stimulate the spread of cancer, pointing to it as evidence that chemotherapy doesn't work and even makes cancer worse. Show More Summary
The words “cancer” and “breast cancer” have always caused fear in the hearts of most people and are seldom spoken unless
(Reuters Health) - Jewish women of European descent may be at risk for additional genetic mutations that increase their risk of breast cancer, according to a new study.
(Reuters) - European regulators on Friday recommended against granting approval to a breast cancer drug being developed by Nektar Therapeutics and Daiichi Sankyo's German unit.
Of the women who carry the mutated BRCA1/2 genes, 45-65 percent will develop breast cancer, and 15-39 percent will develop ovarian cancer. Many women elect to undergo preventive surgeries that can significantly increase life expectancy, but can impact later fertility. Show More Summary
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article pexamines the likelihood of carrying another cancer-predisposing mutation in BRCA1, BRCA2 or another breast cancer gene among women of Ashkenazi Jewish ancestry with breast cancer who do not carry one of the founder mutations.
Medical News Today have found the 10 best breast cancer blogs that offer educational information, inspiration, and support for people with breast cancer.
(The JAMA Network Journals) Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing...Show More Summary
(Institute for Operations Research and the Management Sciences) Of the women who carry the mutated BRCA1/2 genes, 45-65 percent will develop breast cancer, and 15-39 percent will develop ovarian cancer. Many women elect to undergo preventive surgeries that can significantly increase life expectancy, but can impact later fertility. Show More Summary
Although Maryam Mirzakhani died of breast cancer at just 40 years old, she left a lasting legacy in the field of mathematics.
Many myths and misconceptions surround breast cancer, the most frequently diagnosed cancer in women. In 2017, almost 253,000 new cases will be diagnosed in women, according to the American Cancer Society. Myth: Breast cancer can be caused by antiperspirants, deodorants or underwire bras.
At the Rovira i Virgili University in Catalan, Spain, researchers have developed and patented a microfluidic device for detecting circulating tumor cells within whole blood that originate from breast cancer tumors and which are responsible for metastasis. Show More Summary
(Reuters) - The U.S. Food and Drug Administration (FDA) on Monday approved Puma Biotechnology Inc's lead drug to treat patients with a type of early-stage breast cancer.
Patients who have neoadjuvant radiation therapy have a significantly lower risk of developing a second primary tumor at any site, report investigators.
(American College of Surgeons) Women with breast cancer who undergo nipple-sparing mastectomy have a low rate of the cancer returning within the first five years, when most recurrences in the breast are diagnosed, findings of a single-center study show.